U S PHYSICAL THERAPY INC /NV USPH revenue by segment, product and geography
In its fiscal year ending 2025-12-31, U S PHYSICAL THERAPY INC /NV reported revenue across 3 products and services; the largest, Net Patient Revenues, was $650M, 82.3% of the filed sum (+16.0% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Net Patient Revenues$650M82.3%+16.0% yoy
- Other Revenues Including Management Contract Revenues And Industrial Injury Prevention Services Revenues$131M16.5%+17.8% yoy
- Management Contract Revenues$9.6M1.2%-2.0% yoy
Members sum to the consolidated $781M for this period.
- Net Patient Revenues$164M82.1%+7.7% yoy
- Other Revenues Including Management Contract Revenues And Industrial Injury Prevention Services Revenues$34M17.0%+8.7% yoy
- Management Contract Revenues$1.8M0.9%-28.0% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.